We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in ... Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment. Show more
Danaher Schedules Second Quarter 2024 Earnings Conference Call PR Newswire WASHINGTON, June 24, 2024 WASHINGTON, June 24, 2024 /PRNewswire/ -- Danaher Corporation (NYSE:Β DHR) announced that it...
Danaher appoints Julie Sawyer Montgomery to Executive Vice President for Diagnostics PR Newswire WASHINGTON, June 19, 2024 WASHINGTON, June 19, 2024 /PRNewswire/ -- Danaher Corporation (NYSE:...
Danaher Appoints Martin Stumpe to New Role of Chief Data & Artificial Intelligence Officer PR Newswire WASHINGTON, June 5, 2024 Move reflects increasing investment in AI as driving force for...
Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis PR Newswire WASHINGTON, May 9, 2024 The Danaher Beacon for Brain Injury Diagnostics seeks to...
Danaher to Present at Bank of America Securities Healthcare Conference PR Newswire WASHINGTON, May 7, 2024 WASHINGTON, May 7, 2024 /PRNewswire/ --Β Danaher Corporation (NYSE:Β DHR) announced that...
Danaher Announces Quarterly Dividend PR Newswire WASHINGTON, May 7, 2024 WASHINGTON, May 7, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has...
Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREEβ’ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow Cytometry PR...
Danaher Reports First Quarter 2024 Results PR Newswire WASHINGTON, April 23, 2024 WASHINGTON, April 23, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced...
Period β | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 3.58 | 1.43194272229 | 250.01 | 258.29 | 247.2 | 4654120 | 253.04937137 | CS |
4 | 0.28 | 0.110536496783 | 253.31 | 269.11 | 246.09 | 3628216 | 257.81130626 | CS |
12 | 7.59 | 3.08536585366 | 246 | 269.11 | 230.74 | 2935471 | 253.19328803 | CS |
26 | 23.51 | 10.2181849791 | 230.08 | 269.11 | 222.53 | 2797559 | 247.88928498 | CS |
52 | 14.73 | 6.16679226325 | 238.86 | 269.61 | 182.09 | 2864399 | 238.6111835 | CS |
156 | -14.87 | -5.5390002235 | 268.46 | 333.96 | 182.09 | 2698728 | 260.05762185 | CS |
260 | 111.58 | 78.5719315541 | 142.01 | 333.96 | 119.6 | 3108246 | 218.76599838 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions